IRF2 and B-cell chronic lymphocytic leukemia: Currently, in the absence of information about the pathways in which lnc-IRF2-3 and lnc-KIAA1755-4 participate in CLL cells, as well as their potential interactions, it is hard to speculate whether the two lncRNAs affect TTFT and OS synergistically or independently of each other.